Clinical and Microbiological Effects of a Sanguinaria‐Containing Mouthrinse and Dentifrice With and Without Fluoride During 6 Months of Use

Autor: Kopczyk, Raymond A., Abrams, Herbert, Brown, Albert T., Matheny, James L., Kaplan, Alan L.
Zdroj: Journal of Periodontology; October 1991, Vol. 62 Issue: 10 p617-622, 6p
Abstrakt: The purpose of this studywas to test the efficacy and safety of sanguinaria‐containing regimens with and without fluoride using the American Dental Association guidelines for evaluating chemotherapeutic agents. The study was a 6‐month, double‐blind, 4‐cell, placebo‐controlled, parallel investigation involving 120 subjects. Following screening procedures, subjects were randomly assigned to 4 groups. Group 1 received a dentifrice containing 0.075% sanguinaria extract (SaE) and 2.0% zinc chloride (ZnCl2) in a dicalcium phosphate base, plus an oral rinse containing 0.03% SaE and 0.2% ZnCl2‐ Group 2 received identical products without SaE or ZnCl2. Group 3 received a dentifrice containing 0.8% sodium monofluorophosphate, 0.075% SaE, and 0.05% ZnCl2in a silica base, plus an oral rinse containing 0.03% SaE and 0.2% ZnCl2. Group 4 products were identical to those of Group 3 but without SaE and ZnCI2. Supragingival plaque and gingival inflammation were scored at 0, 1, 2, 1.5, 3, 4.5, and 6 months; bleeding upon probing was measured at 1, 1.5, 3, and 6 months. Microbiological samples were taken from plaque, tongue, and cheek areas. The active products produced statistically significantly lower scores than the placebo agents for all indices (P<.0001). Six‐month plaque scores were 13.1% lower for Group 1 and 17.4% lower for Group 3 compared to placebo products. When the Plaque Severity Index was applied, the percentage reductions were 33% for Group 1 and 41% for Group 3 compared to placebos. Gingival inflammation scores were 16.7% lower for Group 1 and 18.1% lower for Group 3 at 6 months compared to placebo scores. Gingival bleeding upon probing scores were 31.5% lower for Group 1 and 41.2% lower for Group 3 compared to placebo groups at 6 months. Microbiological changes were not significant. Only 1 subject experienced an adverse reaction attributable to the use of active products. The active regimens of dentifrice plus oral rinse were significantly better than placebos and were clinically safe, with no evidence of deleterious microbiological changes. J Periodontol 1991;62:617–622.
Databáze: Supplemental Index